Primary Care Gender Affirming Hormone Therapy Initiation Guidelines

Released in March 2023 to support primary care clinicians to initiate gender affirming hormone therapy (GAHT) for adults in a primary care setting.

Download the guidelines here (latest version 29/3/23)

Primary Care GAHT Guidelines_Web_29 Mar

Endorsed by RNZCGP: The Royal New Zealand College of General Practitioners

Individual documents from the guideline 

Patient information sheets:

Primary Care GAHT Guidelines_Patient information sheet_Oestrogen

Primary Care GAHT Guidelines_Patient information sheet_Testosterone

Injection guidance for health professionals

Primary Care GAHT Guidelines_Testosterone Administration

The following information sheets have been made to support healthcare professionals but are not part of the above guidelines:

A summary of the evidence and risks of using progesterone as part of E-GAHT – written for patients but shared here for clinicians to use if useful:

Progesterone patient info sheet for people taking E-GAHT

Testosterone Gel update: please email for prescriber and patient information sheets (see  also: https://healthify.nz/medicines-a-z/t/testosterone-gel/)

Trans health peer support for primary care clinicians in Aotearoa:

(email: rona.carroll@otago.ac.nz for further info)

• Join the Professional Association for Transgender Health Aotearoa (PATHA)
• Trans health GP peer group (meets on zoom)